SCHEMBL65393

SCHEMBL65393

CC(C#N)N1CCOCC1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
ACHE P22303 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GAA P10253 1/20 0.36
LMNA P02545 3/20 0.35
HTT P42858 2/20 0.35
HPGD P15428 2/20 0.35
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
CTSS P25774 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
KCNA5 P22460 1/20 0.33
MAPT P10636 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27570522 0.98 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2ACHEL3MBTL1KDM4E
SCHEMBL5478452 0.82 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2ACHEL3MBTL1KDM4E
SCHEMBL3409567 0.82
SCHEMBL11597630 0.82 TSHR (0.39)
SCHEMBL66078 0.77
SCHEMBL6830731 0.77
SCHEMBL17393478 0.76 KCNA5 (0.36) ALDH1A1SMN1; SMN2LMNAHPGDKMT2A
SCHEMBL947453 0.76 SMN1; SMN2 (0.35) ALDH1A1SMN1; SMN2LMNAHPGDKMT2A
SCHEMBL17675447 0.76 ALDH1A1 (0.33) ALDH1A1SMN1; SMN2LMNAHPGDKMT2A
SCHEMBL3180035 0.75 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2ACHEKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 583 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3400281-A1 COATED BLEACH CATALYST(S) Dalli-Werke GmbH & Co. KG (DE) 2018-11-14 EP claimed
WO-2017118543-A1 COATED BLEACH CATALYST(S) DALLI-WERKE GMBH & CO. KG (DE) 2017-07-13 WO claimed
US-20100203154-A1 Elasmobranch-Repelling Compounds, Methods of Use and Devices STROUD ERIC MATTHEW 2010-08-12 US claimed
EP-1678287-B1 DISPENSER CONTAINING LIQUID BLEACHING COMPOSITION RECKITT BENCKISER UK LTD (GB) 2007-08-29 EP claimed
WO-2006088793-A1 ELASMOBRANCH-REPELLING COMPOUNDS, METHODS OF USE AND DEVICES SHARK DEFENSE LLC (US) 2006-08-24 WO claimed
EP-1678287-A1 LIQUID BLEACHING COMPOSITION Reckitt Benckiser (UK) LIMITED (GB) 2006-07-12 EP claimed
EP-1157090-B1 METHOD OF PREPARING MULTI-PHASE MOULDED DETERGENT AND/OR CLEANING AGENT ARTICLES HENKEL KGAA (DE) 2005-09-21 EP claimed
WO-2005042686-A1 LIQUID BLEACHING COMPOSITION RECKITT BENCKISER (UK) LIMITED (GB) 2005-05-12 WO claimed
US-6743564-B2 A POSITIVE RESIST FORMULATION CONSISTS OF NITRILE CONTAINING TERT-AMINE COMPOUND, AN ORGANIC SOLVENT AND A BASE RESIN HAVING AN ACIDIC FUNCTIONAL GROUP WHICH IS PROTECTED WITH AN ACID LABILE GROUP, A PHOTOACID GENERATOR SHIN-ETSU CHEMICAL CO., LTD. (JP) 2004-06-01 US claimed
EP-0743574-B1 Migration imaging members XEROX CORP (US) 2000-12-27 EP claimed
EP-0743573-B1 Method for obtaining image contrast migration imaging members XEROX CORP (US) 2000-09-06 EP claimed
EP-0129819-B1 METHOD OF IMPREGNATING AND ENVELOPING ELECTRICAL COILS SIEMENS AKTIENGESELLSCHAFT (DE) 1987-01-07 EP claimed
EP-0129819-A1 Method of impregnating and enveloping electrical coils SIEMENS AKTIENGESELLSCHAFT (DE) 1985-01-02 EP claimed
US-6392091-B1 None US disclosed
EP-4660703-A2 METAL-CONTAINING FILM PATTERNING PROCESS Shin-Etsu Chemical Co., Ltd. (JP) 2025-12-10 EP disclosed
US-20250372377-A1 METAL-CONTAINING FILM PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-12-04 US disclosed
US-4203980-A BACTERICIDES, POTENTIATORS HOFFMANN-LA ROCHE INC. (US) 1980-05-20 US disclosed
US-4180578-A 2,4-Diamino-5-(4'-methylthio)benzylpyrimidenes, compounds, compositions and method of use Ludwig Heumann, & Co. GmbH (DE) 1979-12-25 US disclosed
US-4052553-A BACTERICIDE, ANTIMALARIAL BURROUGHS WELLCOME CO. (US) 1977-10-04 US disclosed
US-3931181-A BACTERICIDE HOFFMANN-LA ROCHE INC. (US) 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100203154-A1 Elasmobranch-Repelling Compounds, Methods of Use and Devices ELOC, ELOVL3, ELOVL6 ALDH1A1 2284/4885SMN1; SMN2 522/4885ACHE 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.